Российский университет дружбы народов Минобрнауки России, Москва, Россия
COVID-19 has seen a rise in cardiovascular diseases (CVD). Treatment (rehabilitation) of COVID-19 survivors is one of the most difficult tasks, and non-drug correction of lipid metabolism in COVID-19 survivors is complicated by the low level of research on this issue. Aim. To conduct a comparative assessment of lipid metabolism and to estimate the efficacy of COVID-19 patients at the stages of rehabilitation in a sanatorium. Material and methods. The study enrolled 117 patients with CVD and after endovascular treatment (EV) who underwent COVID-19 for the last 6 months. Three groups for non-drug treatment with intranasal B1 electrophoresis and low-intensity infrared laser irradiation (LILI) were formed in patients with CVD who underwent COVID-19. Results and discussion. A significant increase in total cholesterol (TC) and triglycerides (TG) was found in 75.5% of patients after COVID-19, which was reflected in the electrocardiogram (ECG) in the form of right ventricular (RV) overstress. In addition to drug therapy, a combination of intranasal drug electrophoresis B1 and low-intensity infrared laser radiation (LILI) in pulsed mode (l=904 nm, power (PM) – 8-10 W/cm2, pulse duration 100-150 ns, frequency 80- 10000 Hz) on projection zones of the liver (angle of the 9th intercostal space in front/right and behind/right 5 minutes each) with special physical exercises can become as a method of additional lipid-correcting action. Lipidogram values in patients with IBI, HD and MI differ significantly, with the prevalence of total cholesterol levels, especially in patients with CAD and MI after a history of covid-infection, demonstrating the negative impact of viral infection on metabolic processes. Physiotherapeutic treatment in sanatoriums helped to eliminate lipid-vascular shifts – potential risks of thrombotic complications. Conclusion. Lipid metabolism correction in patients with CVD after COVID-19 allows reducing the risk of complications of the underlying disease and increasing the efficiency at the stage of recovery (rehabilitation) in a sanatorium.
cardiovascular pathology, follow-up treatment, sanatorium conditions, COVID-19
1. Amiyanc V.Yu., Pavlenko V.V. Znachenie bezbolevoy ishemii miokarda vo vremya fizicheskih trenirovok u bol'nyh bez pri- stupov stenokardii posle aortokoronarnogo shuntirovaniya. Medicinskiy Vestnik Severnogo Kavkaza. 2017; 1(4): 29-34. https://doi.org/10.14300/mnnc.2015.10082
2. Kulikova N.G., Zhilokov.Z.G., Chheidze T., Tkachenko A.S. K voprosu o primenenii lazernoy terapii v stomatologii. 2022: 21-27.
3. Boycov S.A. Gripp, novaya koronovirusnaya infekciya i serdechno-sosudistaya zabolevaemost'. Kardiologicheskiy Vestnik. 2021; 16(1): 59-64. https://doi.org/10.17116/Cardiobulletin2021160115
4. Hamurzoeva S.Sh., Kulikova N.G. Puti snizheniya invalidnosti u lic trudosposobnogo vozrasta. Problemy social'noy gigieny, zdravoohraneniya i istorii mediciny. 2013; T.1.6(1): 29-31.
5. Gluschenko R.A., Irklienko E.K. Serdechno-sosudistaya zabolevaemost' - odna iz vazhneyshih problem zdravoohraneniya. Medicina i organizaciya zdravoohraneniya. 2019; 4(1): 25-28.
6. Vsemirnaya organizaciya zdravoohraneniya. Klinicheskoe rukovodstvo po vedeniyu pacientov s tyazheloy ostroy respiratornoy infekciey pri podozrenii na inficirovanie novym koronavirusom (2019-nCoV). Vremennye rekomendacii. 25 yanvarya 2020 g. 2020: 50 c.
7. Demograficheskiy ezhegodnik Rossii 2020: statisticheskiy sbornik. Oficial'noe izdanie. M. Goskomstat Rossii. 2020: 158-194.
8. Jurev V.K., Moiseeva K.E., Alekseeva A.V., Kharbediya Sh.D. Parent appraisal of accessibility and quality of general red Revisit banter no Americana be Hypertension. 2018: 592 p.
9. Ivanova G.E. Medicinskaya reabilitaciya pri novoy koronavirusnoy infekcii (COVID-19). Fizicheskaya i reabilitacionnaya medicina, medicinskaya reabilitaciya. 2020; 2(2): 140-189. https://doi.org/10.36425/rehab34231
10. Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. European Journal of Clinical Investigation. 2020; 50(3): e13209. https://doi.org/10.1111/eci.13209
11. Joanne S. Ingwall Energy metabolism in heart failure and remodeling. Cardiovascular Research. 2019; 33(81): 412-419. https://doi.org/10.1093/cvr/cvn301
12. Brant L.C., Nascimento B.R., Teixera R.A., Lopes M.A., Nalta D.C., Oliveira G.M., Ribeiro A.L. Excess of cardiovascular deaths during the COVID-19 pandemic in Brazillian capital cities. Heart. 2020; 106(24): 1898-1905. https://doi.org/10.1136/heartjnl-2020-317663
13. Demkina A.E., Morozov S.P., Vladzymyrskyy A.V., Kljashtorny V.G., Guseva O.I., Pugachev P.S., Artemova O.R., Reshetnikov R.V., Gombolevskiy V.A., Ryabinina M.N. Risk factors for outcomes of COVID-19 patient: an observation study of patients in Russia. 2020: 14 p.
14. Vasyuk Yu.A. Mitohondrial'naya disfunkciya v patogeneze ostrogo infarkta miokarda: principy diagnostiki i terapii miokardial'nymi citoprotektorami. Rossiyskie medicinskie vesti. 2008; 13(2): 36-41.
15. Lopaschuk L. et al. Myocardial Fatty Acid Metabolism in Health and Disease. Physiological Reviews. 2019; 22(90): 207-258. https://doi.org/10.1152/physrev.00015.2009
16. Holger M. Nef, Albrecht Elsässer, Helge Möllmann, Mohammed Abdel-Hadi et al. Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study. Clinical Research in Cardiology. 2021; 110(2): 292-301. https://doi.org/10.1007/s00392-020-01780-0
17. Aronson F., Vard Dzh., Viner G. Naglyadnaya kardiologiya. M. GOETAR - Media. 2011: 350 c.
